Anti-Rel B antibody [EPR26077-23]
- 20ul selling size
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(3 Publications)
Rabbit Recombinant Monoclonal Rel B antibody. Suitable for WB and reacts with Recombinant fragment - Mouse, Human, Mouse, Rat samples. Cited in 3 publications.
View Alternative Names
Transcription factor RelB, Relb
- WB
Lab
Western blot - Anti-Rel B antibody [EPR26077-23] (AB309084)
Blocking and dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-Rel B antibody [EPR26077-23] (ab309084) at 1/1000 dilution
Lane 1:
Raji (human burkitts lymphoma b lymphocyte) whole cell lysate at 20 µg
Lane 2:
Daudi (human Burkitt's lymphoma lymphoblast) whole cell lysate at 20 µg
Lane 3:
RAW 264.7 (mouse abelson murine leukemia virus-induced tumor macrophage) whole cell lysate at 20 µg
Lane 4:
PC-12 (rat adrenal gland pheochromocytoma cell) whole cell lysate at 20 µg
Lane 5:
A20 (mouse reticum sarcoma b lymphocyte) whole cell lysate at 20 µg
Lane 6:
Mouse thymus tissue lysate at 20 µg
Lane 7:
Rat thymus tissue lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 60 kDa,70 kDa
false
Exposure time: 180s
- WB
Supplier Data
Western blot - Anti-Rel B antibody [EPR26077-23] (AB309084)
Blocking and diluting buffer and concentration : 5% NFDM/TBST This antibody does not cross-react with mouse NF-kB p65. In Western blot, anti-His antibody (ab213204) staining at 1/5000 dilution. Exposure time : 6 seconds.
Lane 1:
His-tagged mouse Rel B fragment at 10 ng
Lane 2:
His-tagged mouse NF-kB p65 recombinant protein
Observed band size: 19 kDa
false
Exposure time: 6s
Related conjugates and formulations (1)
-
Anti-Rel B antibody [EPR26077-23] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Rel B serves as a critical component of the alternative NF-κB signaling pathway. It often forms a complex with another NF-κB family member called p52. This complex controls the transcription of genes involved in the immune response cell survival and differentiation. Additionally Rel B contributes to the development of secondary lymphoid organs and modulation of immune responses.
Pathways
Rel B integrates into the non-canonical NF-κB signaling pathway also influencing the canonical pathway to a lesser extent. In the non-canonical pathway Rel B interacts with NIK and p100 to influence immune cell function. This involvement makes Rel B essential in processes like adaptive immunity and inflammatory responses. The protein p52 closely associates with Rel B aiding its activity in these pathways.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (3)
Recent publications for all applications. Explore the full list and refine your search
Scientific reports 15:31037 PubMed40849525
2025
Applications
Unspecified application
Species
Unspecified reactive species
EMBO reports 26:3917-3936 PubMed40615576
2025
Applications
Unspecified application
Species
Unspecified reactive species
Immunity 57:973-986.e7 PubMed38697117
2024
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com